Sensorion Announces Approval to Initiate amended Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity in France
MONTPELLIER, France--(BUSINESS WIRE)--Oct 24, 2022--
MONTPELLIER, France--(BUSINESS WIRE)--Oct 24, 2022--